Omada Health (OMDA) Stock Price, News & Analysis

Company Overview

Omada Health, Inc. is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines connected health devices, digital tools, health coaching and clinical support to help members improve their health and manage conditions such as diabetes, hypertension and musculoskeletal disorders.

The company’s services are designed for employers, health plans and other healthcare organizations seeking to support populations with ongoing healthcare needs. Omada’s programs may include personalized care plans, remote monitoring, educational resources, behavioral health support and access to clinicians or specialized care teams. The company primarily serves members in the United States through partnerships with organizations that sponsor or provide healthcare benefits.

Omada Health was founded in 2011 by Sean Duffy and Adrian James. Sean Duffy serves as the company’s co-founder and chief executive officer. Omada became a publicly traded company on the Nasdaq under the symbol OMDA in 2025.

Key Stats

• Today's Range: $20.32 to $20.98
• 50-Day Range: $19.11 to $24.99
• 52-Week Range: $10.28 to $26.92
• Volume: 1.25 million shs
• Average Volume: 1.46 million shs
• Market Capitalization: $1.25 billion
• P/E Ratio: 407.40
• Dividend Yield: N/A
• Price Target: $26.67
• Consensus Rating: Moderate Buy

Omada Health Stock Analysis - MarketRank™

Omada Health scored higher than 74% of companies evaluated by MarketBeat, and ranked 154th out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Omada Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.71, and is based on no strong buy ratings, 11 buy ratings, 2 hold ratings, and 1 sell rating.

Upside Potential

Omada Health has a consensus price target of $26.67, representing about 30.9% upside from its current price of $20.37.

Amount of Analyst Coverage

Omada Health has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 100.00%

Earnings Growth

Earnings for Omada Health are expected to grow by 100.00% in the coming year, from $0.09 to $0.18 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Omada Health is 407.40, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 44.60.

Price to Earnings Ratio vs. Sector

The P/E ratio of Omada Health is 407.40, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 273.67.

Price to Book Value per Share Ratio

Omada Health has a P/B Ratio of 5.13. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

13.04% of the float of Omada Health has been sold short.

Short Interest Ratio / Days to Cover

Omada Health has a short interest ratio ("days to cover") of 5.93.

Change versus previous month

Short interest in Omada Health has recently increased by 30.10%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Omada Health does not currently pay a dividend.

Dividend Growth

Omada Health does not have a long track record of dividend growth.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: 0.82

News Sentiment

Omada Health has a news sentiment score of 0.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Omada Health this week, compared to 4 articles on an average week.

MarketBeat Follows

5 people have added Omada Health to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Omada Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,843,167.00 in company stock.

Percentage Held by Insiders

6.38% of the stock of Omada Health is held by insiders.

Percentage Held by Institutions

Omada Health has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 10/02/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:OMDA
• Previous Symbol: NASDAQ:OMDA
• CIK: 1611115
• Web: www.omadahealth.com
• Phone: (888) 987-8337
• Fax: N/A
• Employees: 946
• Year Founded: 2011

Price Target and Rating

• Average Price Target for Omada Health: $26.67
• High Price Target: $35.00
• Low Price Target: $18.00
• Potential Upside/Downside: +30.9%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.71
• Research Coverage: 14 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.05
• Trailing P/E Ratio: 407.40
• Forward P/E Ratio: 226.33
• P/E Growth: N/A
• Net Income: -$12.78 million
• Net Margins: 1.39%
• Pretax Margin: 1.39%
• Return on Equity: 2.60%
• Return on Assets: 1.98%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.91
• Quick Ratio: 3.85

Sales & Book Value

• Annual Sales: $260.21 million
• Price / Sales: 4.79
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $3.97 per share
• Price / Book: 5.13

Miscellaneous

• Outstanding Shares: 61,220,000
• Free Float: 57,311,000
• Market Cap: $1.25 billion
• Optionable: N/A
• Beta: 2.03